Zdrowie i gospodarka · 27/02/2019

FDA Releases Draft Guidance on Quality Considerations for Continuous Manufacturing of Small Molecule Oral Drug Products

The US Food and Drug Administration (FDA) has made available a draft guidance document outlining key quality considerations for continuous manufacturing of small molecule, solid oral drug products, with the aim of supporting the development and implementation of this technology in the pharmaceutical industry.